Latest News in the pharma Industry
Market News
Biogen to acquire first-in-class Phase IIb ready asset for cognitive impairment
12 Mar 2018
PF-04958242 is an AMPA receptor potentiator designed to facilitate neurotransmission.
Read more
Keeping pace with the global topical and transdermal business boom
11 Mar 2018
MedPharm invests in $0.75 million cutting-edge instrumentation to further automated testing and expands workforce.
Read more
Hovione divestment marks its commitment to supplying highly specialized APIs
8 Mar 2018
Portuguese company exits the large volume business of contrast media to concentrate on its CDMO business.
Read more
Major trends for pharma packaging in 2018
7 Mar 2018
Experts forecast the personalised medicines, intelligent packaging and regulatory deadlines as the industry's biggest development.
Read more
Saneca wins significant tablet development and manufacturing contract
6 Mar 2018
The agreement includes the manufacture of 600 million enteric, chewable and film-coated tablets.
Read more
Novel drug delivery technologies for value-added medicines
5 Mar 2018
Licensing agreement enables Recipharm to co-develop new value-added medicines for its customers utilising Altus’ patented Intellitab and Flexitab drug delivery technologies.
Read more
International investor influx in South East Asia
1 Mar 2018
ASEAN Economic Community and relaxed rules on foreign ownership driving increases in international investment and partnerships.
Read more
TraceLink's network approach gets pioneering German biotech EU FMD compliant
1 Mar 2018
biosyn chooses a solution that ensures on-time compliance and delivers the required scalability.
Read more
Catalent completes $4.6 million expansion at Singapore clinical supply facility
28 Feb 2018
Expansion supports multinational customers’ growing needs for full clinical supply services and provides flexible solutions for local customers in the Asia-Pacific region.
Read more
ProJect Pharmaceutics expands facilities for formulation and lyophilization process development
28 Feb 2018
Expansions to meet safety requirements for GMO S2 and BSL-2 biological products.
Read more
Lonza expands encapsulation and HPAPI capabilities in North America
27 Feb 2018
Customers to have the option of one partner from concept to market for their encapsulated drug products
Read more
Acquisition to expand Merck’s leading immuno-oncology pipeline
27 Feb 2018
Proposed acquisition of Viralytics will add investigational oncolytic immunotherapy, Cavatak, to Merck's pipeline.
Read more